Eisai CoSTU:EII +0.24%74 OCF Margin % is 1.99% as of Mar. 2026, which is 84% below its 10-year median of 12.69. GuruFocus rates STU:EII with a GF Score™ of 74/100 and a GF Value™ of €30.90 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 959 Drug Manufacturers companies, Eisai Co ranks worse than 55.27% on this metric.
The historical rank and industry rank for Eisai Co's OCF Margin % or its related term are showing as below:
STU:EII'
s OCF Margin % Range Over the Past 10 Years
Min: -0.24 Med: 12.69 Max: 24.94
Current: 7.32
During the past 13 years, the highest OCF Margin % of Eisai Co was 24.94%. The lowest was -0.24%. And the median was 12.69%.
STU:EII's OCF Margin % is ranked worse than 55.27% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs STU:EII: 7.32
Eisai Co OCF Margin % Related Terms
Eisai Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Eisai Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eisai Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eisai Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Eisai Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eisai Co (STU:EII) has a OCF Margin % of 1.99% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eisai Co and its competitors. This is 84% below median its historical median of 12.69. According to the industry distribution chart, Eisai Co ranks #530 out of 959 companies in the Drug Manufacturers industry, placing it in the top 55.3%.
Is Eisai Co's OCF Margin % too high?
Eisai Co's current OCF Margin % of 1.99% is 84% below median its 10-year median of 12.69. The Drug Manufacturers industry median OCF Margin % is 9.95. Eisai Co's value of 1.99% is 80% below this industry median. Based on the distribution chart, Eisai Co ranks #530 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Eisai Co has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Eisai Co ranks #530 out of 959 companies for OCF Margin %. This places Eisai Co in the lower half of its industry. The industry median OCF Margin % is 9.95. Eisai Co's value of 1.99% is 80% below this benchmark. While the company's 10-year median is 12.69 vs. the industry median of 9.95, Eisai Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eisai Co's current OCF Margin % of 1.99% is 80% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eisai Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eisai Co's current OCF Margin % is 1.99%, which is 84% below median its own 10-year median of 12.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (STU:EII) is currently considered Significantly Undervalued. The stock's GF Value™ is €30.90, compared to a current price of €21.11 — trading 31.7% below its estimated fair value. The current OCF Margin % is 1.99%, which is 84% below median its 10-year median of 12.69 and 80% below the Drug Manufacturers industry median of 9.95. Eisai Co's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Eisai Co (STU:EII), the current OCF Margin % is 1.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eisai Co (STU:EII) Overvalued in 2026?
Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued.
The current stock price of €21.11 is trading 31.7% below its estimated GF Value™ of €30.90.
GuruFocus considers Eisai Co to be Significantly Undervalued.
Key valuation signals for STU:EII:
OCF Margin %: 1.99% (84% below median its 10-year median of 12.69)
GF Value™: €30.90 vs. price of €21.11 (31.7% below fair value)
Industry Position: 80% below the Drug Manufacturers median (#530 of 959)
No single metric tells the full story. See the STU:EII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
74GF Score
Get the complete analysis for STU:EII
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:EII has been successfully added to your 
